An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread
Clinical trial NCT02737475 · COMPLETED
Trial details
- NCT number
- NCT02737475
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-17
- Primary completion
- 2020-11-02
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.